Evidence map›Paper›PMID 19345147›Full record

ArticleThe Lancet. Neurology2009

Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study.

Susan B Bressman, Deborah Raymond, Tania Fuchs, Gary A Heiman, Laurie J Ozelius, Rachel Saunders-Pullman

Abstract read
In one paragraph

Article in The Lancet. Neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 172 citations in OpenAlex.

  1. Article
  2. Review
  3. From Thanatos to transcription: the emerging biology of THAP proteins.Cellular and molecular life sciences : CMLS · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Movement disorders clinical practice · 2023
    Article
  8. Child Neurology:Neurology · 2023
    Article
  9. Review
  10. Genetic screening in patients of Meige syndrome and blepharospasm.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  11. Emerging role of a systems biology approach to elucidate factors of reduced penetrance: transcriptional changes inMedizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Susan B BressmanDepartment of Neurology, Beth Israel Medical Center, New York, NY 10003, USA. sbressma@chpnet.org
Deborah Raymond
Tania Fuchs
Gary A Heiman
Laurie J Ozelius
Rachel Saunders-Pullman
Icahn School of Medicine at Mount Sinai · USMount Sinai Beth Israel · USAlbert Einstein College of Medicine · USRutgers, The State University of New Jersey · US

Funding

THE CLINICAL-GENETIC SPECTRUM OF CLASSIC DYSTONIAR01NS026656 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BRESSMAN, SUSAN · 1989 to 2003
$2.2M
Gender and Hormonal Differences in Parkinson's DiseaseK23NS047256 · NINDS · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI SAUNDERS-PULLMAN, RACHEL · 2004 to 2008
$869k
NINDS NIH HHS K23 NS047256NINDS NIH HHS K23NS047256NINDS NIH HHS NS26636NINDS NIH HHS R01 NS026656
6 · The paper itself

Abstract

backgroundMutations in THAP1 were recently identified as the cause of DYT6 primary dystonia; a founder mutation was detected in Amish-Mennonite families, and a different mutation was identified in another family of European descent. To assess more broadly the role of this gene, we screened for mutations in families that included one family member who had early-onset, non-focal primary dystonia.

methodsWe identified 36 non-DYT1 multiplex families in which at least one person had non-focal involvement at an age of onset that was younger than 22 years. All three coding exons of THAP1 were sequenced, and the clinical features of individuals with mutations were compared with those of individuals who were negative for mutations in THAP1. Genotype-phenotype differences were also assessed.

findingsOf 36 families, nine (25%) had members with mutations in THAP1, and most were of German, Irish, or Italian ancestry. One family had the Amish-Mennonite founder mutation, whereas the other eight families each had novel, potentially truncating or missense mutations. The clinical features of the families with mutations conformed to the previously described DYT6 phenotype; however, age at onset was extended from 38 years to 49 years. Compared with non-carriers, mutation carriers were younger at onset and their dystonia was more likely to begin in brachial, rather than cervical, muscles, become generalised, and include speech involvement. Genotype-phenotype differences were not found.

interpretationMutations in THAP1 underlie a substantial proportion of early-onset primary dystonia in non-DYT1 families. The clinical features that are characteristic of affected individuals who have mutations in THAP1 include limb and cranial muscle involvement, and speech is often affected.

fundingDystonia Medical Research Foundation; Bachmann-Strauss Dystonia and Parkinson Foundation; National Institute of Neurological Disorders and Stroke; Aaron Aronov Family Foundation.

Indexed as

AdolescentAdultAge of OnsetAmino Acid SequenceApoptosis Regulatory ProteinsChildChild, PreschoolDNA-Binding ProteinsDNA Mutational AnalysisDystoniaFamilyFemaleGenetic TestingHeterozygoteHumansMaleApoptosis Regulatory ProteinsDNA-Binding ProteinsNuclear ProteinsTHAP1 protein, human

Identifiers

PMID19345147
PMCPMC3712754
OpenAlexW2167536895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.